DePue 2013.
Methods |
Cluster‐randomised controlled clinical trial (RCT) Randomisation ratio: 1:1 (village clusters) Superiority design |
|
Participants |
Participants were 268 nationals of American Samoa with type 2 diabetes Inclusion criteria: aged 18 or older, resident in service area, self‐identity as Samoan, physician diagnosis of T2DM, mentally competent and able to consent, unlikely to leave American Samoa for over 4 months, no serious co‐morbidities (e.g. ESRF, cancer) Exclusion criteria: as above Diagnostic criteria: "physician diagnosed" type 2 diabetes |
|
Interventions |
Number of study centres: 1 Treatment before study: not commented upon The intervention was individual education tailored to a person's self‐goals and diabetes risk over the course of a year. Frequency varied depending on risk, from monthly to yearly. Teaching was delivered by nurses and community health workers. High‐risk patients were also seen in group sessions. Intervention occurred at home, at work or at the Tafuna clinic. Control arm received delayed intervention of 12 months. In meantime, they received usual care. Included a telephone call at 6 months to update contact info and encourage participation |
|
Outcomes |
Outcomes reported in abstract of publication: Primary outcome: HbA1c Secondary outcomes:
|
|
Study details |
Run‐in period: recruiting between February 2009 and May 2010. No details on when intervention commenced Study terminated before regular end: no |
|
Publication details |
Language of publication: English Funding: National Institute of Diabetes, Digestive, and Kidney Disorders (R18‐DK075371) Publication status: peer‐reviewed journal |
|
Stated aim of study | Quote from publication: "To evaluate the effectiveness of a culturally adapted, primary care–based nurse–community health worker (CHW) team intervention to support diabetes self‐management on diabetes control and other biologic measures" | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Comment: no data |
Allocation concealment (selection bias) | Unclear risk | Comment: no data |
Blinding of participants and personnel (performance bias) Objective outcomes | Unclear risk | Comment: no data |
Blinding of participants and personnel (performance bias) Subjective outcomes | Unclear risk | Comment: no data |
Blinding of outcome assessment (detection bias) Lab tests: Lipids, HBA1C | Unclear risk | Comment: no data |
Blinding of outcome assessment (detection bias) Subjective outcomes | Unclear risk | Comment: no data |
Incomplete outcome data (attrition bias) Objective outcomes | Unclear risk | Comment: no data |
Incomplete outcome data (attrition bias) Subjective outcomes | Unclear risk | Comment: no data |
Selective reporting (reporting bias) | Unclear risk | Comment: no data |
Other bias | Unclear risk | Comment: no data |